Pediatric cancer recurrence is a crucial area of focus for researchers and healthcare providers, especially considering its significant impact on young patients and their families.New advancements, such as an innovative AI tool, have emerged to revolutionize how we predict cancer relapse in children, particularly for brain tumors known as gliomas.